Autografting with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia. by Treleaven, J, Powles, R, Singhal, S, Horton, C, Kulkarni, S, Hale, G, Waldmann, H, Mehta, J

Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia. by Singhal, S, Powles, R, Horton, C, Shepherd, V, Meller, S, Pinkerton, C, Hale, G, Waldmann, H, Treleaven, J, Mehta, H

Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia. by Tiley, C, Powles, R, Treleaven, J, Catovsky, D, Milan, S, Teo, C, Catalano, J, Mehta, J, Shields, M, Gupta, P

A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone. by O'Sullivan, J, Norman, A, McCready, V, Flux, G, Buffa, F, Johnson, B, Coffey, J, Cook, G, Treleaven, J, Horwich, A, Huddart, R, Parker, C, Dearnaley, D

High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. by O'Sullivan, J, McCready, V, Flux, G, Norman, A, Buffa, F, Chittenden, S, Guy, M, Pomeroy, K, Cook, G, Gadd, J, Treleaven, J, Al-Deen, A, Horwich, A, Huddart, R, Dearnaley, D